US4377513A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for the production of human erythropoietin
Assignee: ASHIDA SHIN 4-2 IWAZONO CHO ASHIYA SHI HYOGO JAPAN
•
Filing: 1981-08-10
•
Granted: 1983-03-22
•
Expires: 2001-08-10
Abstract
Abstract The present invention relates to a process for the production of human erythropoietin. More precisely, the invention relates to a process for the mass production of human erythropoietin, comprising in vivo multiplication of human lymphoblastoid cells capable of producing human erythropoietin, and human erythropoietin production by the multiplied human lymphoblastoid cells. The human erythropoietin production according to the present invention is much higher, in terms of human erythropoietin production per cell, than that attained by conventional processes using in vitro tissue culture; thus, human erythropoietin can be used in a sufficient amount for the prevention and treatment of human diseases.
Inventors
- 👤 Kaname Sugimoto
- 👤 Yasushi Hayashibara
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 19:16
CPC Classifications
C; C12; C12N; C12N15/00; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/505; A; A61; A61K; A61K35/00; A61K35/12; A61K38/00; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822; Y10S435/848; Y10S530/00; Y10S530/808; Y10S530/809; Y10S530/82; Y10S530/826; Y10S530/827; Y10S530/828; Y10S530/834; Y10S530/835; Y10S530/837
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
87 words
A process for the production of human erythropoietin, comprising (1) multiplying human lymphoblastoid cells capable of producing human erythropoietin by transplanting said cells to a non-human warm-blooded animal body, and allowing the multiplied human lymphoblastoid cells to release human erythropoietin, or (2) multiplying human lymphoblastoid cells capable of producing human erythropoietin by allowing said cells to multiply with a device by which the nutrient body fluid of a non-human warm-blooded animal is supplied to said cells, and allowing the multiplied human lymphoblastoid cells to release human erythropoietin.
Claim 2
Dependent Claim
87 words
A process for the production of human erythropoietin, comprising (1) multiplying human lymphoblastoid cells capable of producing human erythropoietin by transplanting said cells to a non-human warm-blooded animal body, and allowing the multiplied human lymphoblastoid cells to release human erythropoietin, or (2) multiplying human lymphoblastoid cells capable of producing human erythropoietin by allowing said cells to multiply with a device by which the nutrient body fluid of a non-human warm-blooded animal is supplied to said cells, and allowing the multiplied human lymphoblastoid cells to release human erythropoietin.
Claim 3
Dependent Claim
41 words
A process as set forth in claim 1, wherein said human lymphoblastoid cells capable of producing human erythropoietin are hybridoma cells derived by means of cell fusion of an established human lymphoblastoid line with human cells capable of producing human erythropoietin.
Claim 4
Dependent Claim
22 words
A process as set forth in claim 2, wherein said human cells capable of producing human erythropoietin are human kidney tumor cells.
Claim 5
Dependent Claim
20 words
A process as set forth in claim 2, wherein said hybrodoma cells are obtained by cell fusion using Sendai virus.
Claim 6
Dependent Claim
20 words
A process as set forth in claim 2, wherein said established human lymphoblastoid line is a human leukemic lymphoblastoid line.
Claim 7
Dependent Claim
19 words
A process as set forth in claim 1, wherein said non-human warm-blooded animal is a poultry or a mammalian.
Claim 8
Dependent Claim
38 words
A process as set forth in claim 1, wherein said multiplied human lymphoblastoid cells are allowed to release human erythropoietin in the presence of one or more members of the group consisting of male hormone and metal ions.
Claim 9
Dependent Claim
28 words
A process as set forth in claim 1, wherein said multiplied human lymphoblastoid cells are allowed to release human erythropoietin under a reduced pressure or a oxygen-reduced atmosphere.
Claim 10
Dependent Claim
20 words
A process as set forth in claim 2, wherein said established lymphoblastoid line is Namalwa, BALL-1, NALL-1, TALL-1, or JBL.
Claim 11
Dependent Claim
38 words
A process as set forth in claim 1, wherein said non-human warm-blooded animal is selected from, the group consisting of chickens, pigeons, dogs, cats, monkeys, goats, pigs, cows, horses, rabbits, guinea pigs, rats, hamsters, mice or new mice.
Claim 12
Dependent Claim
41 words
A process as set forth in claim 2, wherein said multiplied human lymphoblastoid cells are allowed to release human erythropoietin in the presence of one or more members of the group consisting of testosterone and Co ++ and Ni ++ ions.
References Cited (Backward Citations)
US3033753A
Cited
US3865801A
Cited
US4276282A
Cited
US4254095A
Cited
US4285929A
Cited
US4198479A
Cited
US4296025A
Cited
US4303650A
Cited
US4328207A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-03-21 | 1986-09-20 | 1987-03-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-03-21 | 1990-09-20 | 1991-03-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-03-21 | 1994-09-20 | 1995-03-22 | $7700.00 | Window Closed / Lapsed |